Quantcast

Latest Artemisinin Stories

5341c0e931b6a9590e35185d5ac770421
2008-11-07 15:02:17

Representatives from more than 70 countries met in China on Friday for a two-day World Health Organization (WHO) event to exchange ideas on increasing the availability of traditional medicine. The event, which is structured around seminars on regulatory standards and folk medicine in various cultures from Japan to South Africa, is expected to conclude with member countries consenting to expand traditional medicine within their health care systems.  Traditional medicine, which can range...

1180371c97e464683a90ff0c58d6e1b11
2008-10-15 10:20:00

Researchers at the University of Washington have updated a traditional Chinese medicine to create a compound that is more than 1,200 times more specific in killing certain kinds of cancer cells than currently available drugs, heralding the possibility of a more effective chemotherapy drug with minimal side effects. The new compound puts a novel twist on the common anti-malarial drug artemisinin, which is derived from the sweet wormwood plant (Artemisia annua L). Sweet wormwood has been used...

2008-10-13 12:00:36

Amyris-Crystalsev Biocombustiveis (Amyris-Crystalsev Biofuels) announced today that former Brazilian Minister of Agriculture, Roberto Rodrigues, has become the founding member of its strategic advisory board. Amyris-Crystalsev Biofuels is a Brazilian venture formed by Amyris, a U.S.-based next generation renewable fuels company, and Crystalsev, one of Brazil's largest ethanol distributors and marketers. Rodrigues, a recognized leader in agricultural business and production, will advise the...

2008-09-19 15:00:08

Text of report by Nairobi-based online news service of UN regional information network IRIN on 19 September Kampala, 19 September 2008: The Ugandan government is to subsidize the most effective form of malaria treatment sold in the private sector. Although such treatment, Artemisinin Combination Therapy (ACT), is available free in public clinics, for most Ugandans, the first port of call in times of sickness is the local pharmacy. With the help of donors, the drugs will be available...

2008-08-25 09:01:58

Genzyme Corp. (Nasdaq: GENZ), a global leader in biotechnology, and Medicines for Malaria Venture (MMV), a not-for-profit virtual research and development (R&D) organization dedicated to reducing the burden of malaria, announced today a new collaboration with India's Advinus Therapeutics Ltd. The collaboration seeks to develop new, improved treatments for specific patient groups most at risk for malaria, an often fatal infectious disease of developing countries, particularly affecting...

2008-07-18 18:00:11

WASHINGTON - Plans for a large-scale trial of a potential AIDS vaccine are being dropped in favor of a smaller, more focused study, the National Institutes of Health said Thursday. The trial of the vaccine, developed by the Vaccine Research Center at the National Institute of Allergy and Infectious Disease, had been planned to include 2,400 men in the United States in a study called PAVE 100. However, the agency said that it decided that the vaccine did not warrant a trial of this scope....

f83148159fd866cd3cb1b4428b0224bd1
2008-02-12 15:55:00

A one of its kind collaborative study between scientists, health workers and police has led to the arrest of alleged traders of fake anti-malarial drugs in China. The investigation highlights the growing threat posed by fake pharmaceuticals and the difficulties of tracking down those responsible for their manufacture. The investigation, known as "Operation Jupiter," included INTERPOL, the World Health Organization's Western Pacific Regional Office, and the Wellcome Trust-University of...

2006-07-02 13:21:18

WASHINGTON (Reuters) - An allergy drug pulled off the market in 1999 could work to treat malaria, U.S. researchers reported on Sunday. The drug is called astemizol and marketed under the brand name Hismanal by Janssen Pharmaceutica, a unit of Johnson & Johnson, and can kill the Plasmodium falciparum parasite that causes malaria. Researchers from the Johns Hopkins University Schools of Medicine and Public Health tested astemizol in test tubes and in mice. Moderate doses reduced...

2006-07-02 12:00:00

WASHINGTON (Reuters) - An allergy drug pulled off the market in 1999 could work to treat malaria, U.S. researchers reported on Sunday. The drug is called astemizol and marketed under the brand name Hismanal by Janssen Pharmaceutica, a unit of Johnson & Johnson, and can kill the Plasmodium falciparum parasite that causes malaria. Researchers from the Johns Hopkins University Schools of Medicine and Public Health tested astemizol in test tubes and in mice. Moderate doses reduced the numbers...

2006-05-23 08:05:00

By Thomas Atkins ZURICH (Reuters) - Drugmaker Novartis aims to create a one-dose cure for the most dangerous form of malaria in a public partnership to address one of the world's top killer diseases, the Swiss company said on Tuesday. Novartis is launching the project at its Institute for Tropical Diseases (NITD) in Singapore to design a one-dose cure for Plasmodium falciparum, the most dangerous form of malaria, and a treatment for Plasmodium vivax, the most frequent and widely distributed...


Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related